Zobrazeno 1 - 10
of 1 344
pro vyhledávání: '"M. A. Hesselink"'
Autor:
David J. Kopsky, Ruben P. A. van Eijk, Janna K. Warendorf, Jan M. Keppel Hesselink, Nicolette C. Notermans, Alexander F. J. E. Vrancken
Publikováno v:
Trials, Vol 23, Iss 1, Pp 1-12 (2022)
Abstract Background Patients with chronic idiopathic axonal polyneuropathy (CIAP) can have neuropathic pain that significantly impacts quality of life. Oral neuropathic pain medication often has insufficient pain relief and side effects. Topical phen
Externí odkaz:
https://doaj.org/article/db56635dbdde4c95a546042ab8944751
Autor:
Stathis Banakas
Publikováno v:
Arbitration International. 11:222-224
Towards a European Civil Code, edited by A. S. Hartkamp, M. W. Hesselink, E. H. Hondius, C. E. Du Perron and J. B. M. Vranken: Published by Ars Aequi Libri-Nijmegen – Dordrecht/Boston/London, Martinus Nijhoff Publishers (1994, ix and 464 pp., incl.
Autor:
Banakas, Stathis
Publikováno v:
Arbitration International; June 1995, Vol. 11 Issue: 2 p222-224, 3p
Publikováno v:
Pharmaceuticals, Vol 11, Iss 4, p 122 (2018)
Background: Phenytoin cream applied topically has been explored in neuropathic pain conditions. In several case series, phenytoin 5% and 10% cream could reduce pain in a clinically relevant way with a fast onset of action within 30 min, and with posi
Externí odkaz:
https://doaj.org/article/e8bb0b956b6f423698eec1560961e509
Autor:
Jan M Keppel Hesselink, Nicolette C. Notermans, Alexander F.J.E. Vrancken, David J Kopsky, Ruben P A van Eijk
Publikováno v:
Journal of Pain Research. 13:877-882
Purpose Topical analgesics are an upcoming treatment option for neuropathic pain. In this observational study, we performed a double-blind placebo-controlled response test (DOBRET) in patients with polyneuropathy to determine the personalized analges
Autor:
Jan M Keppel Hesselink
Publikováno v:
Journal of Pain Research. 13:123-130
Ceruletide (CRL) is a decapeptide, originating from the skin of a tropical frog, and is many times more potent that cholecystokinin (CCK) in a number of assays. The compound was first isolated and characterized around 50 years ago, and its analgesic
Publikováno v:
Journal of pain research. 15
David J Kopsky,1,2 Jan M Keppel Hesselink,1 Alan L Russell,3 Alexander FJE Vrancken2 1Institute for Neuropathic Pain, Amsterdam, the Netherlands; 2Department of Neurology, Brain Centre University Medical Center Utrecht, Utrecht University, Utrecht, t
Publikováno v:
Pharmaceuticals, Vol 11, Iss 2, p 53 (2018)
BACKGROUND: Neuropathic pain can be disabling, and is often difficult to treat. Within a year, over half of all patients stop taking their prescribed neuropathic pain medication, which is most probably due to side effects or disappointing analgesic r
Externí odkaz:
https://doaj.org/article/0e732725dcc847febdc55ba85c4323b9
Publikováno v:
Journal of Ophthalmology, Vol 2015 (2015)
Retinopathy is a threat to the eyesight, and glaucoma and diabetes are the main causes for the damage of retinal cells. Recent insights pointed out a common pathogenetic pathway for both disorders, based on chronic inflammation. Palmitoylethanolamide
Externí odkaz:
https://doaj.org/article/caee3ba225e740cf81ee721870c5c663
Publikováno v:
Case Reports in Medicine, Vol 2015 (2015)
Baclofen 5% cream can be used for the treatment of neuropathic pain. We describe an unusual case of a neuropathic pain patient with spinal cord injury. A 71-year-old woman with a partial spinal cord injury lesion at L4 complained of tingling, pins an
Externí odkaz:
https://doaj.org/article/4504deb169a6442b9a5b562a104bac2f